74
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Machine Learning-Based Predictive Modeling of Diabetic Nephropathy in Type 2 Diabetes Using Integrated Biomarkers: A Single-Center Retrospective Study

, , , , , & show all
Pages 1987-1997 | Received 02 Feb 2024, Accepted 16 Apr 2024, Published online: 09 May 2024

References

  • Thipsawat S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: a review of the literature. Diab Vasc Dis Res. 2021;18(6):14791641211058856. doi:10.1177/14791641211058856
  • Gupta S, Dominguez M, Golestaneh L. Diabetic Kidney Disease: an Update. Med Clin North Am. 2023;107(4):689–705. doi:10.1016/j.mcna.2023.03.004
  • Gupta R, Woo K, Yi JA. Epidemiology of end-stage kidney disease. Semin Vasc Surg. 2021;34(1):71–78. doi:10.1053/j.semvascsurg.2021.02.010
  • Cheneke W, Suleman S, Yemane T, et al. Assessment of glycemic control using glycated hemoglobin among diabetic patients in Jimma University specialized hospital, Ethiopia. BMC Res Notes. 2016;9:96. doi:10.1186/s13104-016-1921-x
  • Hadjkacem F, Triki F, Frikha H, et al. Masked arterial hypertension in patients with type 2 diabetes mellitus: prevalence, associated factors and cardiovascular impact. Ann Cardiol Angeiol. 2022;71(3):136–140. doi:10.1016/j.ancard.2021.10.018
  • Vernooij LM, van Klei WA, Moons KG, et al. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery. Cochrane Database Syst Rev. 2021;12(12):CD013139. doi:10.1002/14651858.CD013139.pub2
  • Fang Z, Hang D, Wang K, et al. Risk prediction models for colorectal cancer: evaluating the discrimination due to added biomarkers. Int, J, Cancer. 2021;149(5):1021–1030. doi:10.1002/ijc.33621
  • Gao J, Ye F, Han F, et al. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma. Front Immunol. 2022;13:956679. doi:10.3389/fimmu.2022.956679
  • Motawi TK, et al. Potential serum biomarkers for early detection of diabetic nephropathy. Diabet Res Clin Pract. 2018;136:150–158. doi:10.1016/j.diabres.2017.12.007
  • Penno G, Solini A, Bonora E, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens. 2011;29(9):1802–1809. doi:10.1097/HJH.0b013e3283495cd6
  • Han H, Chen Y, Yang H, et al. Identification and Verification of Diagnostic Biomarkers for Glomerular Injury in Diabetic Nephropathy Based on Machine Learning Algorithms. Front Endocrinol. 2022;13:876960. doi:10.3389/fendo.2022.876960
  • Yu K, Li S, Wang C, et al. APOC1 as a novel diagnostic biomarker for DN based on machine learning algorithms and experiment. Front Endocrinol. 2023;14:1102634. doi:10.3389/fendo.2023.1102634
  • American Diabetes A. Classification and Diagnosis of Diabetes: standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15–S33. doi:10.2337/dc21-S002
  • Ikizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020;76(3 Suppl 1):S1–S107. doi:10.1053/j.ajkd.2020.05.006
  • Valkenborg D, Rousseau A-J, Geubbelmans M, et al. Support vector machines. Am J Orthod Dentofacial Orthop. 2023;164(5):754–757. doi:10.1016/j.ajodo.2023.08.003
  • Elshewey AM, Shams MY, El-Rashidy N, et al. Bayesian Optimization with Support Vector Machine Model for Parkinson Disease Classification. Sensors. 2023;23(4):2085. doi:10.3390/s23042085
  • Almansour NA, Syed HF, Khayat NR, et al. Neural network and support vector machine for the prediction of chronic kidney disease: a comparative study. Comput Biol Med. 2019;109:101–111. doi:10.1016/j.compbiomed.2019.04.017
  • Zou Y, Zhao L, Zhang J, et al. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease. Ren Fail. 2022;44(1):562–570. doi:10.1080/0886022x.2022.2056053
  • Leung RK, Wang Y, Ma RC, et al. Using a multi-staged strategy based on machine learning and mathematical modeling to predict genotype-phenotype risk patterns in diabetic kidney disease: a prospective case-control cohort analysis. BMC Nephrol. 2013;14(1):162. doi:10.1186/1471-2369-14-162
  • Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38(10):1933–1953. doi:10.1093/clinchem/38.10.1933
  • Nikolov D, Stoyanova VK, Vladimirova-Kitova L, et al. Analysis and evaluation of correlation between DNA polymorphism in the genes MTHFR, PAI-1 and serum creatinine, creatinine clearance and albumin/creatinine ratio in morning urine of patients with type 2 diabetes mellitus and diabetic nephropathy. Folia Med (Plovdiv). 2022;64(6):896–904. doi:10.3897/folmed.64.e67912
  • Cao P, Huang B, Hong M, et al. Association of amino acids related to urea cycle with risk of diabetic nephropathy in two independent cross-sectional studies of Chinese adults. Front Endocrinol. 2022;13:983747. doi:10.3389/fendo.2022.983747
  • Tonneijck L, Muskiet MHA, Smits MM, et al. Glomerular Hyperfiltration in Diabetes: mechanisms, Clinical Significance, and Treatment. J Am Soc Nephrol. 2017;28(4):1023–1039. doi:10.1681/ASN.2016060666
  • Ono S, Ono Y, Koide D, et al. Association Between Routine Nephropathy Monitoring and Subsequent Change in Estimated Glomerular Filtration Rate in Patients With Diabetes Mellitus: a Japanese Non-Elderly Cohort Study. J Epidemiol. 2020;30(8):326–331. doi:10.2188/jea.JE20180255
  • Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study. Kidney Int. 1992;41(4):822–828. doi:10.1038/ki.1992.126
  • Saini DC, Kochar A, Poonia R. Clinical correlation of diabetic retinopathy with nephropathy and neuropathy. Indian J Ophthalmol. 2021;69(11):3364–3368. doi:10.4103/ijo.IJO_1237_21